Voglibose is an α-glycosidase inhibitor that improves postprandial hyperglycemia and increases glucagon-like peptide-1 (GLP-1) secretion in patients with type 2 diabetes. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.